| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.tridentlifeline.com | |
| Market Cap | 218.48 Cr. | |
| Enterprise Value(EV) | 224.56 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 5.23 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 36.32 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 38.54 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 40.60 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 4.68 | Calculated using Price: 190.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.15 Cr. | 11,499,200 Shares |
| FaceValue | 10 | |
| About Trident Lifeline Ltd. | ||
| The company is engaged in the manufacturing and marketing of quality finished dosages. It is one of the fastest growing pharmaceutical companies in the SME segment providing unprecedented quality of healthcare products. It deals in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. | ||
| 1 Day |
|
+2.70% |
| 1 Week |
|
-3.92% |
| 1 Month |
|
-6.40% |
| 3 Month |
|
-2.56% |
| 6 Month |
|
+28.38% |
| 1 Year |
|
+55.74% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 2 years | 2022-03 | 2023-03 | |
| Return on Equity (%) | 83.23 | 24.05 | |
| Return on Capital Employed (%) | 43.21 | 24.32 | |
| Return on Assets (%) | 30.72 | 16.83 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 5 | 46 | 49 | |
| Non Curr. Liab. | 0 | 2 | 2 | |
| Curr. Liab. | 8 | 11 | 12 | |
| Minority Int. | ||||
| Equity & Liab. | 13 | 59 | 63 | |
| Non Curr. Assets | 2 | 9 | 15 | |
| Curr. Assets | 11 | 49 | 48 | |
| Misc. Exp. not W/O | 0 | 0 | ||
| Total Assets | 13 | 59 | 63 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 22 | 32 | |
| Other Income | 1 | 1 | |
| Total Income | 22 | 33 | |
| Total Expenditure | -19 | -25 | |
| PBIDT | 3 | 7 | |
| Interest | 0 | 0 | |
| Depreciation | 0 | 0 | |
| Taxation | 1 | -1 | |
| Exceptional Items | |||
| PAT | 4 | 6 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 4 | 6 | |
| Adjusted EPS | 5 | 5 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -17 | |
| Cash Fr. Inv. | 0 | -7 | |
| Cash Fr. Finan. | 1 | 38 | |
| Net Change | 0 | 14 | |
| Cash & Cash Eqvt | 0 | 14 |
|
Thu, 30 Nov 2023
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Trident Lifeline Limited has submitted to the exchange Intimation regarding Resignation of Company Secretary and Compliance Officer of the Company. |
|
Thu, 30 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 30.11.2023. Trident Lifeline Limited has submitted to the exchange Outcome of Board Meeting held on 30.11.2023. |
|
Fri, 10 Nov 2023
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations 2011 please find enclosed herewith disclosure received from Mr. Hardik J Desai Trustee of Hardik Desai Family Trust in terms of sub regulation (2) of the said regulation in the format prescribed. |
| Fri, 08 Dec 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors
StockEdge Social